AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS

Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFS

The early-onset broad-spectrum antiviral effect of Ampligen has been observed to stimulate strong innate immune response, offering potential therapeutic benefits for people with ME/CFS or Post-COVID chronic fatigue